Vertex Pharmaceuticals (VRTX ... their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside ...

to its Board of Directors. Dr. Hughes brings extensive experience from his leadership roles at major biopharmaceutical companies, including Vertex Pharmaceuticals and Novartis. Monte Rosa's CEO ...

Vertex Pharmaceuticals Incorporated today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other stocks that will make you rich in 2025. Jurrien Timmer, Director of ...

Investors need to pay close attention to Vertex Pharmaceuticals (VRTX ... for both Lilly and Novo," BMO Capital Markets managing director of biopharma equity research Evan Seigerman explains.

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX ... Keating, M.D., Co-Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program at Columbia University and investigator in the ALYFTREK ...

Need some inspiration for stocks to buy right now? Here are my top 10 buys -- in no particular order -- for 2025 and beyond.

Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025. His analysis reflects cautious optimism, emphasizing ...

Nextracker announced today that Dan Shugar, Founder and CEO, will participate in a fireside chat at the Goldman Sachs Energy, CleanTech & Utilities Conference. The session is scheduled for 2:00 p.m.

Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025. His analysis reflects cautious optimism, emphasizing ...